• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Governance Committee

The Governance Committee supports strong oversight, accountability, and compliance across the Alliance.

Committee members advise the Board on governance matters, review relevant policies and procedures, and help ensure the Alliance meets its legal, regulatory, and organizational responsibilities.


Co-Chairs of the Governance Committee

Mary-Ellen Bench

Mary-Ellen BenchMary-Ellen Bench advises on land use planning and municipal affairs at StrategyCorp. She has over 30 years of experience in municipal public service, mostly in leadership roles, where she was often engaged on project teams outside of the traditional legal role because of her practical approach to achieving solutions that work for all parties. She has also actively participated in many governance reviews and has sat on many not-for-profit boards based in Canada and the United States. Mary-Ellen also holds the Certified In-House Counsel (CIC.C) designation from the Canadian Bar Association — In-House Lawyers and the University of Toronto’s Rotman School of Management.


Marcela Santos

Marcela SantosMarcela Santos is a psychologist with a master’s degree in Social Inclusion of People with Disabilities. Her father, Alfredo Santos, lived with ALS/MND for 16 years, and she was one of his primary caregivers. He had a very positive outlook on ALS/MND, and the way he embraced it was passed to his daughter. He passed away on February 8, 2020.

Marcela has dedicated her academic and professional life to the care of people with disabilities in Colombia through public institutions, private organizations, and NGOs. Since 2014, she has volunteered as a psychologist, providing free psychotherapy to people living with ALS/MND and their caregivers. Her personal experience with her father, combined with her professional expertise, allows her to provide more meaningful care.


Committee Members

Catherine Cummings, CAE, MBA

Catherine CummingsCathy Cummings has an eclectic mix of experience in the Canadian not-for-profit sector, including the National Payroll Institute, the Canadian Bar Association, the Canadian Corporate Counsel Association, and the International Alliance of ALS/MND Associations. Cathy has also volunteered extensively with United Way, the Canadian Society of Association Executives, and many charities, including ALS Ontario, ALS Canada, and Ceridian Cares. She holds an MBA from Athabasca University and the Certified Association Executive (CAE) designation.

On a personal note, Cathy is married to her husband, Marty, has three children, and has a mission nicknamed the “Bouquet Project,” where she is trying to reverse the statistic that people are 10 times more likely to complain than praise.


Laura Freveletti

Laura FrevelettiLaura Freveletti is Chief Executive Officer of the Les Turner ALS Foundation. She comes to the ALS field with 30 years of experience in executive leadership, most recently as Senior Program Officer at The Allstate Foundation. Throughout her career, she has been dedicated to driving social impact through strategic planning, fundraising, and innovative programming, with experience as a senior fundraising executive at the YMCA of Metropolitan Chicago and Lyric Opera of Chicago, as well as service as board president of Sudden Infant Death Services of Illinois.

Having lost her brother-in-law to ALS, Laura is committed to advancing research and improving care for the ALS community.


Jennifer Hjelle

Jennifer HjelleJennifer Hjelle has been helping to advance the non-profit health sector for more than 20 years. She has focused her career on engaging local communities in advancing mission priorities through fundraising, advocacy, and volunteerism.

Jennifer started her tenure at The ALS Association in 2012, leading all areas of operations for Minnesota, North Dakota, and South Dakota. She is now the Chief Community Engagement Officer, where she leads all care programming and community engagement across the country.


Michele Messmer Uccelli

Michele Messmer UccelliMichele Messmer Uccelli holds a master’s degree in Disability Studies from the University of Leeds. She has more than 25 years of experience in research and project development promoting empowerment in health at national and international levels, working in the United States and Italy. Her broad experience includes advocacy, stakeholder engagement, and social health research.

For many years, she was Director of Client and Healthcare Professional Programs and Professional Education at the Italian Multiple Sclerosis Society. Michele has participated in numerous international working groups and committees in the field of neuroscience. She continues to promote patient involvement in healthcare as a consultant to major Italian hospitals in oncology and neuroscience. She is the author of numerous scientific publications and has several years of experience as a volunteer in an Italian hospice dedicated to ALS and oncology.


Clare Sullivan

Clare SullivanClare Sullivan is a results-oriented leader with more than 20 years of experience in leadership and advocacy across health, community, infrastructure, and government. She is driven to make Australia a better place to live and to improve the lives of Australians in her professional and personal life.

Clare comes to the role of CEO of MND Australia having delivered significant policy change, billions of dollars in funding programs, and greater engagement for a diverse range of organizations. She now oversees millions of dollars in research funding while supporting state associations in service delivery to improve the lives of people living with ALS/MND, and their families and caregivers.

Drawing on her experience as a CEO, Chief of Staff, and senior executive, Clare is driven to deliver strong results for MND Australia, working to continually improve the care and support services available for people living with ALS/MND while relentlessly pursuing a cure.


Riccardo Zuccarino

Riccardo ZuccarinoRiccardo Zuccarino is a physician specializing in physical medicine and rehabilitation in Italy. Since completing his specialty training, he has focused on the rehabilitation management of neuromuscular diseases. His clinical and research work has centred on hereditary neuropathies and ALS/MND, and he has contributed to the design of several rehabilitation studies on Charcot-Marie-Tooth disease and ALS/MND. He currently provides outpatient and home-based care for people living with ALS/MND.

Since 2015, Riccardo has served as one of the clinical experts and consultants for the Italian Association of Amyotrophic Lateral Sclerosis (AISLA), supporting people living with ALS/MND and their families through one of the organization’s dedicated Listening Centres. Since 2011, he has also been part of the NeMO Clinical Centers, serving as Physiatrist Manager at the Arenzano Centre and, since 2021, as Clinical Director of the NeMO Trento Clinical Center.

Riccardo is a member of the Inherited Neuropathy Consortium, the Peripheral Nerve Society, and the European Reference Network. From 2018 to 2020, he worked at the University of Iowa, where he coordinated an international research group focused on Charcot-Marie-Tooth disease, a hereditary peripheral neuropathy.

Primary Sidebar

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

  • Phil Rossall, UK

    Phil Rossall, UK

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Jon Newsome, USA

    Jon Newsome, USA

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Rosie Riley, USA

    Rosie Riley, USA

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Len Johnrose, England

    Len Johnrose, England

  • Greg Heydet, USA

    Greg Heydet, USA

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Willi Klein, UK

    Willi Klein, UK

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Ali Var, Turkey

    Ali Var, Turkey

  • Susan Keldani, USA

    Susan Keldani, USA

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Timmy, Belgium

    Timmy, Belgium

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Jean Waters, UK

    Jean Waters, UK

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login